What is the prevalence of HIV-associated vacuolar myelopathy (VM)?

Updated: May 07, 2018
  • Author: Krupa Pandey, MD; Chief Editor: Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM  more...
  • Print


Before the introduction of highly active antiretroviral therapy (HAART), vacuolar myelopathy (VM) occurred in 5–20% of adult HIV patients in clinical studies and in 25–55% of adult HIV patients in histologic studies. Since its introduction, fewer than 10% of AIDS patients develop VM.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!